Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Evaluation of Genomic Applications in Practice and Prevention (EGAPP)

This website is archived for historical purposes and is no longer being maintained or updated.

The EGAPP Working Group was established in 2005 to support the development of a systematic process for assessing the available evidence regarding the validity and utility of rapidly emerging genetic tests for clinical practice. This independent, multidisciplinary panel prioritizes and selects tests, reviews CDC-commissioned evidence reports and other contextual factors, highlights critical knowledge gaps, and provides guidance on appropriate use of genetic tests in specific clinical scenarios.

What's New

  • Meeting:

    The EGAPP Working Group held a meeting on October 27-28, 2014

  • Article:

    The EGAPP Working Group has published a new article entitled “The EGAPP Initiative: Lessons Learned”

  • Meeting:

    The last EWG meeting was on August 19 and 20, 2013.

  • Article [PDF 656 KB]:

    The EGAPP Working Group has published a new article entitled “Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies” [PDF 656 KB] in collaboration with Kaiser Permanente Center for Health Research.

More

EGAPP Recommendations

More

TOP